ArticleAutonomic neuroscience : basic & clinical2022

A new lead: Sacubitril-valsartan's unique benefit in HFrEF could lie with sympathoinhibition.

Sangeetha Nathaniel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.